Sajid Mahmood

Sajid Mahmood has a wealth of experience in the field of cancer research and immunotherapy. Sajid has worked at various organizations and has held positions such as Principal Scientist, Senior Scientist, and Scientist. At Fate Therapeutics Inc, they have led multiple projects, developed scientific strategies, and actively collaborated with cross-functional departments. Sajid has also worked on optimizing mouse models and conducting pre-clinical studies for the development of CAR-iNK products. Prior to this, at the Fred Hutchinson Cancer Research Center, Sajid was involved in the development of CAR-T cells to target Acute Myeloid Leukemia (AML), employing novel genetic modification strategies. Sajid has also gained experience in infectious diseases and global health through a fellowship program. Overall, Sajid Mahmood's work experience showcases their expertise in cancer immunotherapy and their contributions to the field.

Sajid Mahmood has a diverse education history. Sajid obtained a Doctor of Philosophy (Ph.D.) in Immunology from the University of Manitoba, Canada, from 2008 to 2014. Prior to that, they received a Diploma in the General Medical Lab Program/Electrocardiogram and Phlebotomy Technician from the Robetech Institute in Toronto, Ontario, Canada, in 2006. Mahmood also holds a Master's degree in Molecular Virology from Kansas State University, USA, which they completed between 2000 and 2003. Additionally, they have an M.Sc. (Hons) in Microbiology from the University of Agriculture in Faisalabad, Pakistan, earned from 1995 to 1997. Lastly, Mahmood has a Doctor of Veterinary Medicine (DVM) degree from the Faculty of Veterinary Sciences at the University of Agriculture, Faisalabad, Pakistan. No specific dates are provided for this qualification.